Mucormycosis in pre‐COVID‐19 and COVID‐19 era: A study of prevalence, risk factors and clinical features
Abstract Objective Mucormycosis is a rare yet devastating fungal disease with a frequently fatal outcome. The purpose of this study was to compare the prevalence of mucormycosis, evaluate its risk factors, and assess the patients' outcomes in pre‐COVID‐19 and COVID‐19 era. Methods In this retro...
Main Authors: | Parisa Arjmand, Milad Bahrami, Zahra Eslami Mohammadie, Mohammadhossein Taherynejad, Negar Yeganeh Khorasani, Hassan Mehrad‐Majd, Imaneh Roshanzamir, Mehdi Bakhshaee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Laryngoscope Investigative Otolaryngology |
Subjects: | |
Online Access: | https://doi.org/10.1002/lio2.899 |
Similar Items
-
Let's talk about mucormycosis emergency with COVID-19: Invest in future
by: Kamlesh Malik, et al.
Published: (2022-01-01) -
View of mucormycosis during the era of COVID-19 infection: A cross-sectional study
by: Ossama M Zakaria, et al.
Published: (2023-01-01) -
Hematological Indices in COVID-19 Patients with Rhinosinusitis Mucormycosis
by: Seyedeh Sabereh Mojtahedi, et al.
Published: (2024-03-01) -
COVID-19 and mucormycosis: A black fungus disaster?
by: Suchira Chillana, et al.
Published: (2022-01-01) -
Risk Factors for COVID-19 Associated Mucormycosis: The Ophthalmologist’s Perspective
by: Alper Bilgic, et al.
Published: (2022-03-01)